ArticleBMC pediatrics2026
Advancing enhanced recovery after surgery protocols for pediatric laparoscopic-assisted small intestinal malformation repair.
Article in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to evaluate the safety and efficacy of enhanced recovery after surgery (ERAS) protocols in pediatric patients undergoing laparoscopic-assisted resection for Meckel’s diverticulum (MD) or intestinal duplication (ID).
methodsA retrospective cohort analysis was conducted on 96 pediatric patients who underwent laparoscopic-assisted resection for MD or ID at our institution between January 2017 and July 2025, covering the periods pre- and post-ERAS implementation. Patients were stratified into two groups: the ERAS group (n = 49), managed per ERAS protocols, and the traditional (TRAD) group (n = 47), receiving conventional perioperative care. Demographic characteristics, perioperative outcomes, and laboratory parameters were systematically compared between groups.
resultsAll procedures were performed by a consistent surgical team, with no significant differences in baseline characteristics between groups (all P > 0.05). The ERAS group exhibited superior outcomes: (1) Recovery: shorter median postoperative length of stay (LOS) (7.00 vs. 9.00 days, P < 0.001) and consistently lower FLACC pain scores at 2–48 h postoperatively (P < 0.001); (2) Laboratory markers: comparable preoperative values (all P > 0.05), but higher glucose levels at anesthesia induction (P < 0.001) and favorable postoperative laboratory profiles (lower C-reactive protein [CRP], neutrophil [NEUT] count, and glucose; higher prealbumin; all P < 0.05); (3) Clinical benefits: reduced urinary catheter utilization and duration (both P < 0.05), accelerated achievement of recovery milestones (mobility, flatus, oral intake, total enteral nutrition initiation, and intravenous infusion cessation; all P < 0.001), and lower healthcare costs (P < 0.001) without compromising safety (complication and readmission rates, both P > 0.05). ERAS-related advantages were more pronounced, with a non-significant trend toward higher parental satisfaction (P = 0.444).
conclusionsERAS protocols safely optimize recovery in pediatric patients undergoing laparoscopic-assisted resection for small intestinal malformations (MD/ID) without adversely affecting clinical outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.